J&J Innovative Medicine

Johnson & Johnson Innovative Medicine is the medicines and therapies business of Johnson & Johnson, focused on advancing healthcare through rigorous science and patient-centered innovation. Its researchers work to develop transformational medicines, bringing discoveries from the laboratory to patients while emphasizing compassion and meaningful impact. The company’s areas of focus include oncology, immunology, neuroscience and cardiopulmonary health.

Its portfolio and development work span medicines and therapies, with products including TREMFYA (guselkumab) and ICOTYDE (icotrokinra), featured in updates on treatment research for Crohn’s disease and plaque psoriasis. Johnson & Johnson Innovative Medicine also shares information about its clinical trials and product pipeline, helping healthcare professionals and patients explore research and available resources. Its online services include a clinical trial finder for healthcare professionals, patient and caregiver resources, and information about pre-approval access. The company also engages with innovation partners through partnership and collaboration opportunities. Through discovery, product development and a focus on data science and digital health, Johnson & Johnson Innovative Medicine aims to shape future treatment options across its healthcare areas.